proline has been researched along with Cicatrix, Hypertrophic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Li, X; Sun, Y; Xiao, M; Yu, W; Zhao, T; Zhou, S | 1 |
| Garner, WL | 1 |
2 other study(ies) available for proline and Cicatrix, Hypertrophic
| Article | Year |
|---|---|
BMS-202, a PD-1/PD-L1 inhibitor, decelerates the pro-fibrotic effects of fibroblasts derived from scar tissues via ERK and TGFβ1/Smad signaling pathways.
Topics: B7-H1 Antigen; Cicatrix, Hypertrophic; Collagen Type I; DNA Nucleotidylexotransferase; Fibroblasts; Fibrosis; Humans; Immune Checkpoint Inhibitors; Programmed Cell Death 1 Receptor; Proline; Signal Transduction | 2022 |
Epidermal regulation of dermal fibroblast activity.
Topics: Adult; Analysis of Variance; Burns; Cell Division; Cells, Cultured; Cicatrix, Hypertrophic; Collagen; Culture Media, Conditioned; Epidermis; Epithelium; Female; Fibroblasts; Humans; Keratinocytes; Linear Models; Male; Mitogens; Proline; Radiopharmaceuticals; Skin; Skin Transplantation; Thymidine; Transplantation, Autologous; Tritium; Wound Healing | 1998 |